February 2023
29 Jul 2024
The global non-invasive blood glucose monitoring system market revenue was valued at USD 26.97 million in 2023 and is poised to grow from USD 33.07 million in 2024 to USD 253.69 million by 2034, with a double-digit CAGR of 22.6% during the forecast period 2024 – 2034. The increasing integration of therapeutic and monitoring features contributed to driving the growth of the non-invasive blood glucose monitoring system market.
The Full Study is Readily Available | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/2405
A non-invasive blood glucose monitoring system measures the amount of glucose in the blood. The information on glucose levels is important in the case of diabetic patients. Non-invasive glucose monitoring offers information on the effects of diabetic medication and diabetic management on glucose levels. It also helps allow patients to detect whether their blood glucose level is high or low.
The increasing demand for non-invasive monitoring of glucose levels and the increasing prevalence of chronic diseases such as diabetes are expected to drive the growth of the market. In addition, the increasing presence of new product launches and strong companies and increasing sedentary lifestyles such as obesity and physical inactivity are further anticipated to drive the growth of the non-invasive blood glucose monitoring system market during the forecast period.
Growing technological advancements to fuel the market growth.
The developing technologies in smart insulin pens are estimated to enhance the growth of the market. The iSenz adapter for modern insulin pens helps to detect insulin levels. This iSenz adapter offers injection angles for diabetic injection site improvement. Easylog is a smart adapter for insulin pens that is connected to the network connection. It helps patients improve their comfort and gives them the proper dosage to manage chronic illnesses such as diabetes and other diseases.
In addition, some other advanced devices include caps that fit insulin pens and involve a sensor to monitor consumption and temperature. Some smart insulin pens help diabetic patients to improve efficiency and accuracy in blood glucose monitoring. These driving factors are expected to drive the growth of the non-invasive blood glucose monitoring system market.
However, accuracy concerns, technological limitations, and patient preferences restrain the market growth. Non-invasive blood glucose monitoring tools are required to demonstrate high efficiency compared to traditional invasive processes. Incorrect readings may lead to inaccurate treatment decisions and compromise the patient's health. In addition, some non-invasive technologies may face challenges in terms of reliability, consistency, and accuracy. These challenges may hinder patient trust and widespread adoption. Furthermore, patient preferences for proven and familiar monitoring methods may motivate their willingness to convert to non-invasive devices. These factors are further responsible for restraining the growth of the non-invasive blood glucose monitoring system market.
| Report Attribute | Key Statistics |
| Market Revenue in 2024 | USD 33.07 Million |
| Market Revenue by 2034 | USD 253.69 Million |
| Market CAGR | 22.6% from 2024 to 2034 |
| Quantitative Units | Revenue in USD million/billion, Volume in units |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2034 |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Recent Innovation in Non-invasive Blood Glucose Monitoring System by Know Labs
Recent Innovation in Non-invasive Blood Glucose Monitoring System by BLUESEMI
Read Also: Blood Pressure Monitoring Devices Market Size and Top 10 Companies
North America dominated the non-invasive blood glucose monitoring system market in 2023. The increasing lifestyle changes, sedentary lifestyle practices, increasing lifestyle disorders and stress, and increasing demand for ono-invasive blood glucose monitoring systems are expected to drive the growth of the market in the region. The U.S. and Canada are the major countries in the market. In addition, the increasing prevalence of diabetes, the growing presence of global and regional vendors, non-profitable organizations, initiatives by the government to create awareness about diabetes management and prevention, and the growing number of product launches are further expected to accelerate the growth of the market.
In the U.S., there are various major companies present in the market of non-invasive blood glucose monitoring systems, such as Medtronic plc, Abbott Laboratories Inc., Nipro Medical Corporation, DexCom, Inc., And many more. These companies and factors are helping to drive the growth of the non-invasive blood glucose monitoring system market in North America.
Asia Pacific is expected to show considerable growth due to the increasing supply and demand of non-invasive blood glucose monitoring systems and the growing number of people suffering from diabetes, growing rapid urbanization, changing lifestyle, and an increasing diabetes burden enhance the growth of accurate and user-friendly glucose monitoring solutions in the region. China, India, Japan, and South Korea are the major countries in the Asia Pacific region. These are the major factors that drive the growth of the non-invasive blood glucose monitoring system market in the Asia Pacific region.
Growing adoption of artificial intelligence and data analytics
Artificial intelligence and big data analytics are revolutionizing digital diabetes management. The market is estimated to grow rapidly as new effective digital diabetes management technologies have become accessible and enable better diabetes control. Healthcare professionals and patients will have access to real-time unstructured and structured data, with the increased growth and use of big data analytics. These opportunities are expected to enhance the growth of the non-invasive blood glucose monitoring system market in the coming years.
Market Segmentation
By Technology
By End User
By Modality
By Distribution Channel
Buy this Research Report@ https://www.precedenceresearch.com/checkout/2405
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308
February 2023
November 2022
February 2024
March 2024